Haemonetics Corp.

NYSE: HAE
Share price (5/17/24): $95.73
Market cap (5/17/24): $4.862 billion

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

16 Haemonetics Corp. Expert Interviews, now on BamSEC.

Powered by Tegus.

Financials Filter

ended 03/30/24 FY 2024

ended 12/30/23 Q3

ended 09/30/23 Q2

ended 07/01/23 Q1

ended 04/01/23 FY 2023

Prospectuses and Registrations Filter

Registration of securities for employees

Updated info for already-effective prospectus

Registration of securities for employees

Registration of securities for employees

Registration of securities for employees

Ownership Filter

Strong Stewart W

Basil Michelle L

Basil Michelle L

News Filter

Reports Fourth Quarter and Fiscal 2024 Results; Provides Fiscal 2025 Guidance

Material Definitive Agreement, Termination of Material Definitive Agreement, New Financial Obligation or Off-Balance Sheet Arrangement, Financial Statements or Exhibits

Completes Acquisition of Attune Medical

Announces Definitive Agreement to Acquire Attune Medical

Reports Third Quarter and Year-To-Date Fiscal 2024 Results; Updates Fiscal 2024 Guidance

Proxies Filter

Additional info about upcoming vote

Definitive proxy

Additional info about upcoming vote

Definitive proxy

Additional info about upcoming vote

Other Filter

Scanned paper annual report submission

Conflict Minerals disclosure

Conflict Minerals disclosure

Conflict Minerals disclosure

Conflict Minerals disclosure